| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.98 | 0.002 | 0.98 | 5 Hydroxytryptamine 1A agonist | 0.903 0.003 DBMET01502 | ||
| 0.973 | 0.002 | 0.973 | Dopamine D2 antagonist | 0.939 0.002 DBMET01502 | ||
| 0.968 | 0.002 | 0.968 | Dopamine antagonist | 0.921 0.003 DBMET01502 | ||
| 0.96 | 0.002 | 0.96 | 5 Hydroxytryptamine 1A antagonist | 0.777 0.003 DBMET01502 | ||
| 0.949 | 0.003 | 0.949 | 5 Hydroxytryptamine antagonist | 0.855 0.003 DBMET01502 | ||
| 0.942 | 0.002 | 0.942 | Alpha adrenoreceptor antagonist | 0.619 0.004 DBMET01502 | ||
| 0.927 | 0.002 | 0.927 | 5 Hydroxytryptamine 1 antagonist | 0.695 0.004 DBMET01502 | ||
| 0.925 | 0.002 | 0.925 | 5 Hydroxytryptamine 2 antagonist | 0.819 0.003 DBMET01502 | ||
| 0.921 | 0.002 | 0.921 | Alpha 1 adrenoreceptor antagonist | 0.584 0.004 DBMET01502 | ||
| 0.917 | 0.002 | 0.917 | Alpha 1a adrenoreceptor antagonist | 0.59 0.004 DBMET01502 | ||
| 0.908 | 0.002 | 0.908 | Alpha 1d adrenoreceptor antagonist | 0.619 0.003 DBMET01502 | ||
| 0.9 | 0.002 | 0.9 | 5 Hydroxytryptamine 2A antagonist | 0.774 0.003 DBMET01502 | ||
| 0.858 | 0.003 | 0.858 | 5 Hydroxytryptamine 1 agonist | 0.704 0.004 DBMET01502 | ||
| 0.837 | 0.004 | 0.837 | Antiadrenergic | 0.572 0.005 DBMET01502 | ||
| 0.837 | 0.004 | 0.837 | Adrenaline antagonist | 0.569 0.005 DBMET01502 | ||
| 0.83 | 0.003 | 0.83 | 5 Hydroxytryptamine 2B antagonist | 0.497 0.005 DBMET01502 | ||
| 0.795 | 0.003 | 0.795 | 5 Hydroxytryptamine 2C antagonist | 0.37 0.006 DBMET01502 | ||
| 0.751 | 0.003 | 0.751 | Alpha 1b adrenoreceptor antagonist | 0.546 0.004 DBMET01502 | ||
| 0.743 | 0.004 | 0.743 | 5 Hydroxytryptamine agonist | 0.477 0.005 DBMET01502 | ||
| 0.672 | 0.004 | 0.672 | 5 Hydroxytryptamine 7 antagonist | 0.464 0.005 DBMET01502 | ||
| 0.632 | 0.004 | 0.632 | Dopamine D4 antagonist | 0.185 0.014 DBMET01502 | ||
| 0.588 | 0.009 | 0.588 | HERG channel blocker | 0.344 0.039 DBMET01502 | ||
| 0.573 | 0.003 | 0.573 | Alpha 1 adrenoreceptor agonist | 0.333 0.004 DBMET01502 | ||
| 0.555 | 0.01 | 0.555 | Potassium channel (Voltage-sensitive) blocker | 0.319 0.044 DBMET01502 | ||
| 0.455 | 0.004 | 0.455 | 5 Hydroxytryptamine 1F antagonist | 0.231 0.009 DBMET01502 | ||
| 0.367 | 0.005 | 0.367 | Dopamine D1 antagonist | 0.25 0.008 DBMET01502 | ||
| 0.4 | 0.059 | 0.4 | MAP kinase kinase 6 inhibitor | 0.275 0.161 DBMET01502 | ||
| 0.345 | 0.005 | 0.345 | Alpha 2a adrenoreceptor antagonist | 0.134 0.026 DBMET01502 | ||
| 0.327 | 0.005 | 0.327 | Sigma receptor antagonist | 0.232 0.008 DBMET01502 | ||
| 0.32 | 0.004 | 0.32 | Alpha adrenoreceptor agonist | 0.148 0.017 DBMET01502 | ||
| 0.342 | 0.034 | 0.342 | Potassium channel blocker | |||
| 0.293 | 0.006 | 0.293 | Dopamine D3 antagonist | 0.125 0.019 DBMET01502 | ||
| 0.284 | 0.011 | 0.284 | MAP kinase kinase 3 inhibitor | 0.246 0.035 DBMET01502 | ||
| 0.255 | 0.004 | 0.255 | Sigma 1 receptor antagonist | 0.085 0.007 DBMET01502 | ||
| 0.269 | 0.021 | 0.269 | Acetylcholine M1 receptor antagonist | 0.212 0.037 DBMET01502 | ||
| 0.24 | 0.012 | 0.24 | Alpha 2 adrenoreceptor antagonist | 0.081 0.065 DBMET01502 | ||
| 0.231 | 0.01 | 0.231 | Acetylcholine agonist | 0.143 0.028 DBMET01502 | ||
| 0.231 | 0.018 | 0.231 | Acetylcholine muscarinic antagonist | 0.164 0.036 DBMET01502 | ||
| 0.212 | 0.01 | 0.212 | 5 Hydroxytryptamine uptake inhibitor | 0.096 0.028 DBMET01502 | ||
| 0.206 | 0.02 | 0.206 | Antihistaminic | |||
| 0.199 | 0.015 | 0.199 | Histamine H1 receptor antagonist | 0.072 0.067 DBMET01502 | ||
| 0.202 | 0.019 | 0.202 | Histamine antagonist | |||
| 0.189 | 0.009 | 0.189 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.185 | 0.035 | 0.185 | Acetylcholine antagonist | 0.112 0.078 DBMET01502 | ||
| 0.186 | 0.036 | 0.186 | Cholinergic antagonist | 0.114 0.08 DBMET01502 | ||
| 0.156 | 0.007 | 0.156 | DNA gyrase inhibitor | 0.1 0.018 DBMET01502 | ||
| 0.24 | 0.106 | 0.24 | Insulysin inhibitor | |||
| 0.154 | 0.033 | 0.154 | 5 Hydroxytryptamine 3A agonist | |||
| 0.13 | 0.023 | 0.13 | Acetylcholine nicotinic agonist | |||
| 0.113 | 0.007 | 0.113 | Nicotinic alpha7 receptor agonist | |||
| 0.114 | 0.015 | 0.114 | Acetylcholine muscarinic agonist | 0.057 0.036 DBMET01502 | ||
| 0.167 | 0.075 | 0.167 | Sigma receptor agonist | |||
| 0.129 | 0.043 | 0.129 | Alpha 2c adrenoreceptor antagonist | |||
| 0.094 | 0.013 | 0.094 | Acetylcholine M1 receptor agonist | |||
| 0.094 | 0.017 | 0.094 | 5 Hydroxytryptamine 2A agonist | |||
| 0.211 | 0.135 | 0.211 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.087 | 0.013 | 0.087 | Dopamine D2 agonist | 0.051 0.026 DBMET01502 | ||
| 0.093 | 0.02 | 0.093 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.09 | 0.02 | 0.09 | Acetylcholine M5 receptor antagonist | |||
| 0.147 | 0.079 | 0.147 | Cholinergic | |||
| 0.081 | 0.012 | 0.081 | Dopamine D5 antagonist | 0.056 0.022 DBMET01502 | ||
| 0.085 | 0.018 | 0.085 | Nicotinic neuronal receptor agonist | |||
| 0.126 | 0.062 | 0.126 | Anesthetic local | 0.094 0.089 DBMET01502 | ||
| 0.096 | 0.032 | 0.096 | Acetylcholine M4 receptor antagonist | |||
| 0.089 | 0.032 | 0.089 | Dopamine agonist | |||
| 0.083 | 0.028 | 0.083 | Acetylcholine M2 receptor antagonist | |||
| 0.066 | 0.013 | 0.066 | Cholesterol esterase inhibitor | |||
| 0.184 | 0.133 | 0.184 | Spasmolytic | |||
| 0.214 | 0.163 | 0.214 | Ca(v)3.3 blocker | |||
| 0.128 | 0.078 | 0.128 | Toll-Like receptor 9 antagonist | |||
| 0.139 | 0.092 | 0.139 | Hexokinase inhibitor | |||
| 0.11 | 0.066 | 0.11 | Alpha 2b adrenoreceptor antagonist | |||
| 0.084 | 0.039 | 0.084 | Lipase inhibitor | |||
| 0.066 | 0.023 | 0.066 | Acetylcholine M2 receptor agonist | |||
| 0.072 | 0.032 | 0.072 | Adrenaline uptake inhibitor | 0.054 0.052 DBMET01502 | ||
| 0.074 | 0.035 | 0.074 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.05 | 0.012 | 0.05 | Acetylcholine M4 receptor agonist | |||
| 0.047 | 0.013 | 0.047 | Glucose-6-phosphate dehydrogenase inhibitor | 0.042 0.019 DBMET01502 | ||
| 0.056 | 0.028 | 0.056 | Alpha 1L adrenoreceptor antagonist | |||
| 0.062 | 0.034 | 0.062 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.206 | 0.181 | 0.206 | Beta lactamase inhibitor | |||
| 0.082 | 0.058 | 0.082 | Caspase 7 inhibitor | |||
| 0.076 | 0.057 | 0.076 | Glutamate receptor agonist | |||
| 0.04 | 0.023 | 0.04 | DNA gyrase subunit B inhibitor | |||
| 0.256 | 0.245 | 0.256 | Caspase 9 stimulant | |||
| 0.13 | 0.121 | 0.131 | Ca2+-transporting ATPase inhibitor | 0.131 0.115 DBMET01502 | DBMET01502 | |
| 0.034 | 0.028 | 0.034 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.097 | 0.092 | 0.097 | Proteasome inhibitor | |||
| 0.034 | 0.03 | 0.034 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.185 | 0.185 | 0.202 | Transcription factor NF kappa B inhibitor | 0.202 0.167 DBMET01502 | DBMET01502 | |
| 0.078 | 0.122 | 0.144 | Toll-Like receptor 4 antagonist | 0.144 0.025 DBMET01502 | DBMET01502 | |
| 0.016 | 0.133 | 0.05 | Opioid kappa receptor agonist | 0.05 0.024 DBMET01502 | DBMET01502 | |
| 0.159 | 0.296 | 0.228 | Analgesic | 0.228 0.205 DBMET01502 | DBMET01502 | |
| 0.004 | 0.193 | 0.065 | Nociceptin (N/OFQ) receptor agonist | 0.065 0.005 DBMET01502 | DBMET01502 | |
| 0.011 | 0.235 | 0.085 | Opioid agonist | 0.085 0.017 DBMET01502 | DBMET01502 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |